F. Hoffmann-La Roche Ltd: Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus

Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.The Elecsys HCV Duo

Related Keywords

Switzerland ,Geneva ,Genè ,Japan ,United States ,America ,Nathalie Meetz ,Birgit Masjost ,Loren Kalm ,Thomas Schinecker ,Sabine Borngr ,Gerard Tobin ,Bruno Eschli ,Genentech ,World Health Organization ,World Hepatitis Alliance ,Roche Group ,Roche Group Media Relations ,Dow Jones Sustainability Indices ,Chugai Pharmaceutical ,Hoffmann ,Oche ,Aunches ,Nnovative ,Ual ,Ntigen ,Ntibody ,Iagnostic ,Pest ,Supporting ,Flight ,Liminate ,Hepatitis ,Virus ,